These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 14727150)
1. Empiric oral monotherapy for hospitalized patients with community-acquired pneumonia: an idea whose time has come. Cunha BA Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):78-81. PubMed ID: 14727150 [No Abstract] [Full Text] [Related]
2. Community acquired pneumonia. Al-Qadi MO; Al-Alwan A; Opal SM; Cillley B; Silverblatt FJ Med Health R I; 2010 Jul; 93(7):196-200. PubMed ID: 20707009 [No Abstract] [Full Text] [Related]
3. Neonatal community-acquired pneumonia: pathogens and treatment. Wang H; Tang J; Xiong Y; Li X; Gonzalez F; Mu D J Paediatr Child Health; 2010 Nov; 46(11):668-72. PubMed ID: 20796185 [TBL] [Abstract][Full Text] [Related]
4. [New quinolones for the treatment of community-acquired pneumonia--contra]. Egger M Dtsch Med Wochenschr; 2003 May; 128(19):1071. PubMed ID: 12736860 [No Abstract] [Full Text] [Related]
5. Severe community-acquired pneumonia: the need to customize empiric therapy. Wunderink RG; Waterer GW Chest; 2001 Oct; 120(4):1053-5. PubMed ID: 11591535 [No Abstract] [Full Text] [Related]
6. Drugs of choice for community-acquired bacterial pneumonia. Med Lett Drugs Ther; 2007 Jul; 49(1266):62-4. PubMed ID: 17652999 [No Abstract] [Full Text] [Related]
7. Treating paediatric community-acquired pneumonia in the era of antimicrobial resistance. Galli L; Montagnani C; Chiappini E; de Martino M Acta Paediatr; 2013 Dec; 102(465):25-33. PubMed ID: 24330270 [TBL] [Abstract][Full Text] [Related]
8. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Lim WS; Baudouin SV; George RC; Hill AT; Jamieson C; Le Jeune I; Macfarlane JT; Read RC; Roberts HJ; Levy ML; Wani M; Woodhead MA; Thorax; 2009 Oct; 64 Suppl 3():iii1-55. PubMed ID: 19783532 [No Abstract] [Full Text] [Related]
9. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association]. Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863 [No Abstract] [Full Text] [Related]
10. [Clinical management of community-acquired pneumonia]. Pachón J; Alcántara Jde D; Cordero E; Lama C; Rivero A Enferm Infecc Microbiol Clin; 2003; 21(7):350-7. PubMed ID: 14525691 [No Abstract] [Full Text] [Related]
12. Empiric therapy of community-acquired pneumonia: guidelines for the perplexed? Cunha BA Chest; 2004 May; 125(5):1913-9. PubMed ID: 15136407 [TBL] [Abstract][Full Text] [Related]
14. Empirical therapy of community-acquired pneumonia: macrolides are not ideal choices. Bartlett JG Semin Respir Infect; 1997 Dec; 12(4):329-33. PubMed ID: 9436960 [TBL] [Abstract][Full Text] [Related]
15. [New quinolones for the treatment of community-acquired pneumonia--pro]. Zimmerli S Dtsch Med Wochenschr; 2003 May; 128(19):1070. PubMed ID: 12736859 [No Abstract] [Full Text] [Related]
16. Bacterial community-acquired pneumonia in children: changes in causative agents. Korppi M; Heiskanen-Kosma T Monaldi Arch Chest Dis; 2001 Apr; 56(2):132-6. PubMed ID: 11499302 [TBL] [Abstract][Full Text] [Related]
17. Macrolides are ideal for empiric therapy of community-acquired pneumonia in the immunocompetent host. Vergis EN; Yu VL Semin Respir Infect; 1997 Dec; 12(4):322-8. PubMed ID: 9436959 [TBL] [Abstract][Full Text] [Related]